FM DECEMBER 2018 ISSUE - digital edition

CASE REPORT DRUG RESISTANCE REGULATORY COPD
letters to the editor
IMMUNOTHERAPY FOR
LUNG
CANCER
WILL CHECKPOINT BLOCKERS ALTER
WELL-ENTRENCHED TREATMENT ALGORITHMS?
ABERNETHY -
AN UNUSUAL
SUSPECT
TACKLING
EMERGING
PATHOGENS
MCI IN DIRE
STRAITS
Refreshing reading
₹ 250.00
VOL 5 | ISSUE 7
PAGES 100
NOVEMBER 2018
FUTUREMEDICINEINDIA.COM
EBV INTERVENTION
IN EMPHYSEMA
Hello,
I would like to mention
about the cover story
on immunotherapy of
November edition. It was very
informative. Including the
suggestions of various expert
specialists really gave a good
awareness on the status of
immunotherapy in the current
scenario. The contents of the
magazine keep up well with
the latest developments in
the field. Both interesting and
refreshing.
Dr Natu Seth,
Pondicherry
Reality of a therapy
Sir,
The cover story on
immunotherapy gives a
good idea on the reality of
the therapy unlike simply
glorifying it as in most
journals. We know that
immunotherapy is not the
way to a complete cure in all
types of cancers and also the
cost implications are never
really mentioned anywhere.
Opinions of the clinicians
are well documented in
the article. I would suggest
that perhaps a story based
on the cost implications of
immunotherapy and the
percentage of the population
who can really afford and
benefit them, including details
on the average cycles of the
therapy given to a different
patient by various clinicians
could be a new approach.
Overall it is a good work
well committed to connecting
the medicine and research
field.
Best Regards.
Dr Alok Saxena
Patna
EBV instructive
Dear sir,
Found the article on EBV
intervention in emphysema
written by Dr. George really
instructive. The contents
including news and research
works are all helpful in
keeping the readers up-todate
in the medical field. All
the best!
Dr Mythily Sawant,
Pune
Unbiased initiative
Sir,
Unbiased and a unique
initiative. The approach really
enables readers including
medical students to get
a good awareness of the
various areas of our discipline.
Includes instructive articles
and latest news such as
published policies and new
drugs and devices approvals.
Dr Raju Vernekar,
Belgaum
& GET 30 %
NOW
Please send me my subscription of FUTURE MEDICINE for (Select your plan)
SUBSCRIBE
One year Rs. 2,100/- Two years Rs. 4,200/- Three years Rs. 6,300/-
OFF
NAME
ADDRESS
CITY
POSTAL CODE
E-MAIL
PHONE
Fill complete details and send it along with the cheque/DD in favour of ‘NEXTGEN SCIENCE MEDIA (P.) LTD.’ to Future Medicine,
5th floor, Wework Zenia, Zenia Building, Hiranandani Business Park, Off. Ghodbunder Road, Thane, Mumbai, MH- 400 607
For NEFT/RTGS : Account No. 50200032001372, IFSC:- HDFC0000684 Name: NextGen Science Media Pvt Ltd, HDFC Bank Ltd,
Kakkanad Branch, Cochin • For more details call - 9594 625 231 or mail - subscribe@futuremedicineindia.com